Viromed Medical AG (XTER:VME) ROE % Adjusted to Book Value: 1.48% (As of Dec. 2025)


XTER:VME Viromed Medical AG XTER:VME
15 GF Score
Price €7.10
! 5 Warning Signs
View Full Analysis

What is Viromed Medical AG ROE % Adjusted to Book Value?

Viromed Medical AG XTER:VME +2.16% 15 ROE % Adjusted to Book Value is 1.48% as of Dec. 2025. GuruFocus rates XTER:VME with a GF Score™ of 15/100. The stock has 5 warning signs investors should review.

Viromed Medical AG's ROE % for the quarter that ended in Dec. 2025 was 11.44%. Viromed Medical AG's PB Ratio for the quarter that ended in Dec. 2025 was 7.71. Viromed Medical AG's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 1.48%.

Viromed Medical AG ROE % Adjusted to Book Value Related Terms

Viromed Medical AG ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Viromed Medical AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viromed Medical AG ROE % Adjusted to Book Value Chart

Viromed Medical AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
0.00 0.00 0.00 0.00 0.80

Viromed Medical AG Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 -0.78 1.48

XTER:VME vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Viromed Medical AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viromed Medical AG ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Viromed Medical AG's ROE % Adjusted to Book Value falls into.


XTER:VME
15GF Score
Viromed Medical AG XTER:VME
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viromed Medical AG ROE % Adjusted to Book Value Calculation

Viromed Medical AG's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.13% / 7.71
=0.80%

Viromed Medical AG's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=11.44% / 7.71
=1.48%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 1.48% mean?
Viromed Medical AG (XTER:VME) has a ROE % Adjusted to Book Value of 1.48% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Viromed Medical AG and its competitors.
Is Viromed Medical AG's ROE % Adjusted to Book Value too high?
Viromed Medical AG's current ROE % Adjusted to Book Value is 1.48%. Overall, Viromed Medical AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's ROE % Adjusted to Book Value compare to ABT and SYK?
Viromed Medical AG's ROE % Adjusted to Book Value of 1.48% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Viromed Medical AG and its competitors. Viromed Medical AG's current ROE % Adjusted to Book Value is 1.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (XTER:VME) has a current ROE % Adjusted to Book Value of 1.48%. The current ROE % Adjusted to Book Value is 1.48%. Viromed Medical AG's overall GF Score™ is 15/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Viromed Medical AG (XTER:VME), the current ROE % Adjusted to Book Value is 1.48% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viromed Medical AG Business Description

Address Hauptstrasse 105, Rellingen, Pinneberg, SH, DEU, 25462
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
15GF Score

Get the complete analysis for XTER:VME

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.10
Price